(Q34234748)

31 July 2017

title

Early measures of cognitive function predict survival in patients with newly diagnosed glioblastoma (English)

1 reference

31 July 2017

Derek R Johnson

1

1 reference

31 July 2017

Allison M Sawyer

2

1 reference

31 July 2017

Christina A Meyers

3

1 reference

31 July 2017

Brian Patrick O'Neill

4

1 reference

31 July 2017

Jeffrey S Wefel

5

1 reference

31 July 2017

publication date

16 April 2012

1 reference

31 July 2017

1 reference

31 July 2017

volume

14

1 reference

31 July 2017

issue

6

1 reference

31 July 2017

page(s)

808-816

1 reference

Exercise behavior, functional capacity, and survival in adults with malignant recurrent glioma

31 July 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3367851

Neurocognitive function in patients with recurrent glioblastoma treated with bevacizumab

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3367851

Response assessment in neuro-oncology (a report of the RANO group): assessment of outcome in trials of diffuse low-grade gliomas.

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3367851

Validation and simplification of the Radiation Therapy Oncology Group recursive partitioning analysis classification for glioblastoma

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3367851

Trail Making Test predicts physical impairment and mortality in older persons

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3367851

Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3367851

Nomograms for predicting survival of patients with newly diagnosed glioblastoma: prognostic factor analysis of EORTC and NCIC trial 26981-22981/CE.3.

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3367851

MGMT gene silencing and benefit from temozolomide in glioblastoma

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3367851

Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3367851

Importance of baseline mini-mental state examination as a prognostic factor for patients with low-grade glioma

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3367851

Trail Making Test A and B: normative data stratified by age and education

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3367851

Demographic characteristics and normative observations for derived-trail making test indices

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3367851

Recursive partitioning analysis (RPA) of prognostic factors in three Radiation Therapy Oncology Group (RTOG) brain metastases trials

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3367851

Application of the Trail Making Test in differentiating neuropsychological impairment of elderly persons.

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3367851

Neuropsychological deficits in symptomatic minor head injury patients after concussion and mild concussion

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3367851

Molecular predictors of progression-free and overall survival in patients with newly diagnosed glioblastoma: a prospective translational study of the German Glioma Network

6 July 2018

1 reference

https://api.crossref.org/works/10.1093%2FNEUONC%2FNOS082

Recursive partitioning analysis of prognostic factors in three Radiation Therapy Oncology Group malignant glioma trials.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNEUONC%2FNOS082

Benton Controlled Oral Word Association Test: reliability and updated norms.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNEUONC%2FNOS082

The Functional Assessment of Cancer Therapy (FACT) scale. Development of a brain subscale and revalidation of the general version (FACT-G) in patients with primary brain tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNEUONC%2FNOS082

Volumetric measurement of brain tumors from MR imaging.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNEUONC%2FNOS082

International Cognition and Cancer Task Force recommendations to harmonise studies of cognitive function in patients with cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNEUONC%2FNOS082

Outcome evaluation in glioblastoma patients using different ranking scores: KPS, GOS, mRS and MRC.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNEUONC%2FNOS082

Multiinstitutional validation of the University of California at San Francisco Low-Grade Glioma Prognostic Scoring System. Clinical article

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNEUONC%2FNOS082

Cognitive function as a predictor of survival in patients with recurrent malignant glioma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNEUONC%2FNOS082

The prognostic value of cognitive functioning in the survival of patients with high-grade glioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNEUONC%2FNOS082

Karnofsky performance status revisited: reliability, validity, and guidelines

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/22508762

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1093/NEUONC/NOS082

1 reference

31 July 2017

1 reference

31 July 2017

1 reference